1. Home
  2. CTW vs BDSX Comparison

CTW vs BDSX Comparison

Compare CTW & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTW

CTW Cayman Class A Ordinary Shares

N/A

Current Price

$2.48

Market Cap

171.6M

Sector

Technology

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$21.82

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTW
BDSX
Founded
2013
2005
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.6M
153.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CTW
BDSX
Price
$2.48
$21.82
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
17.5K
92.2K
Earning Date
05-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$22.41
N/A
Revenue Growth
N/A
24.08
52 Week Low
$1.10
$0.29
52 Week High
$3.14
$24.92

Technical Indicators

Market Signals
Indicator
CTW
BDSX
Relative Strength Index (RSI) 52.76 60.37
Support Level $1.96 $6.63
Resistance Level $3.05 $24.92
Average True Range (ATR) 0.31 2.38
MACD 0.01 -0.03
Stochastic Oscillator 47.52 63.67

Price Performance

Historical Comparison
CTW
BDSX

About CTW CTW Cayman Class A Ordinary Shares

CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: